In this episode, Deciphex CEO Donal O’Shea featured on AI Ireland's podcast to share his journey from academia to entrepreneurship, and how he’s leading the charge in transforming global pathology services with AI. Donal discusses the growing demand for diagnostics, the importance of international collaboration, and how AI can support, not replace, pathologists in delivering faster, more accurate diagnoses around the world.
Published on
April 10, 2025
Category
AI
Discover more
Patholytix
Corporate
Global
AI
AI Improving Drug Safety, Reducing Burden Generating better results during preclinical research
AI improves drug safety assessments so unsafe drugs and compounds never make it to human clinical trials. Leveraging AI to reduce Animal Burden.
Cernostics and Deciphex Announce Strategic Collaboration to Develop AI-Based Histology Diagnostics and Prognostics for Barrett's Esophagus
By combining Deciphex’s unique digital pathology solutions with Cernostics tissue systems pathology approach, the partnership aims to generate novel predictive indicators using AI.
Diagnexia Analytix
Global
.png)
Deciphex Launches Diagnexia Analytix: AI-Driven Pathology Services for Translational Research and Development
Deciphex, the research pathology division of Deciphex, proudly announces the launch of Diagnexia Analytix, a comprehensive pathology service offering that integrates advanced analytics and AI-powered workflows with expert-led diagnostics to elevate study outcomes.
Deciphex Secures €15M Venture Debt Funding from Claret Capital Partners to Accelerate Growth
Strategic growth funding includes €10M immediate drawdown and restructuring of existing facilities to fuel US expansion and UK market leadership
AI Has Arrived in Pathology, And It’s Seeing What We Couldn’t
I think it’s known as Amara’s law that we tend to overestimate the degree of change or innovation over a relatively short period, but underestimate over longer periods of time. It makes sense that the more we project the more difficult it becomes to really foresee the path of development.
Rewriting the Rules of Pathology: Diagnexia's Shift from Service Provider to Vital Partner
Having worked in and alongside histopathology departments for several years, I’ve seen the incredible dedication of teams under relentless pressure. I’ve sat with service leads staring down weeks of case backlogs, watched departments scramble to fill persistent vacancies, and listened to the quiet frustration when traditional outsourcing models didn’t quite meet the need. Pathology is the backbone of so much of modern medicine, yet it often runs in the background, essential but under-resourced, quietly absorbing ever-increasing demand.